| Excellent Care Home Health Services, Inc | |
| 9037 Arrow Route, Suite 140, Rancho Cucamonga, California 91730 | |
| (909) 581-3536 | |
| Name | Excellent Care Home Health Services, Inc |
|---|---|
| Location | 9037 Arrow Route, Suite 140, Rancho Cucamonga, California |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 58183 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 90029, 90048, 90604, 90620, 91745, 92677, 92683, 92801, 92841, 92863 |
| NPI Number | 1881678217 |
| Organization Name | EXCELLENT CARE HOME HEALTH SERVICES, INC. |
| Address | 13139 Central Ave Ste G, Chino, CA 91710 |
| Phone Number | 909-581-3536 |
News Archive
Scientists are on their way to develop a perfect diet pill. The drug, which switches off appetite using hormones that are created naturally in the stomach when it is full, could be the first to be effective in weight loss without side effects.
Neurocrine Biosciences, Inc. has announced that they have resubmitted its New Drug Application (NDA) for indiplon 5 mg and 10 mg capsules for the treatment of insomnia in both adult and elderly patients to the U.S. Food and Drug Administration (FDA).
Researchers at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health and at the Harvard Medical School report that children with autism and gastrointestinal disturbances have altered expression of genes involved in digestion. These variations may contribute to changes in the types of bacteria in their intestines.
Stopping treatment with risperidone to limit side effects risks the return of psychosis or agitation in patients with Alzheimer's disease who have been taking the drug to suppress such symptoms, research shows.
› Verified 7 days ago
| Quality Rating: |
News Archive
Scientists are on their way to develop a perfect diet pill. The drug, which switches off appetite using hormones that are created naturally in the stomach when it is full, could be the first to be effective in weight loss without side effects.
Neurocrine Biosciences, Inc. has announced that they have resubmitted its New Drug Application (NDA) for indiplon 5 mg and 10 mg capsules for the treatment of insomnia in both adult and elderly patients to the U.S. Food and Drug Administration (FDA).
Researchers at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health and at the Harvard Medical School report that children with autism and gastrointestinal disturbances have altered expression of genes involved in digestion. These variations may contribute to changes in the types of bacteria in their intestines.
Stopping treatment with risperidone to limit side effects risks the return of psychosis or agitation in patients with Alzheimer's disease who have been taking the drug to suppress such symptoms, research shows.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 91.2 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 97.1 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 77.9 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.2 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 9.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.4 | 96.4 |
News Archive
Scientists are on their way to develop a perfect diet pill. The drug, which switches off appetite using hormones that are created naturally in the stomach when it is full, could be the first to be effective in weight loss without side effects.
Neurocrine Biosciences, Inc. has announced that they have resubmitted its New Drug Application (NDA) for indiplon 5 mg and 10 mg capsules for the treatment of insomnia in both adult and elderly patients to the U.S. Food and Drug Administration (FDA).
Researchers at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health and at the Harvard Medical School report that children with autism and gastrointestinal disturbances have altered expression of genes involved in digestion. These variations may contribute to changes in the types of bacteria in their intestines.
Stopping treatment with risperidone to limit side effects risks the return of psychosis or agitation in patients with Alzheimer's disease who have been taking the drug to suppress such symptoms, research shows.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 43.4 | 79.6 |
| How often patients got better at getting in and out of bed | 50.7 | 81.1 |
| How often patients got better at bathing | 55.4 | 82.3 |
| How often patients’ breathing improved | 61 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 67.5 | 75 |
| How often home health patients had to be admitted to the hospital | 17.1 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 8 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 81.6 | 94 |
News Archive
Scientists are on their way to develop a perfect diet pill. The drug, which switches off appetite using hormones that are created naturally in the stomach when it is full, could be the first to be effective in weight loss without side effects.
Neurocrine Biosciences, Inc. has announced that they have resubmitted its New Drug Application (NDA) for indiplon 5 mg and 10 mg capsules for the treatment of insomnia in both adult and elderly patients to the U.S. Food and Drug Administration (FDA).
Researchers at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health and at the Harvard Medical School report that children with autism and gastrointestinal disturbances have altered expression of genes involved in digestion. These variations may contribute to changes in the types of bacteria in their intestines.
Stopping treatment with risperidone to limit side effects risks the return of psychosis or agitation in patients with Alzheimer's disease who have been taking the drug to suppress such symptoms, research shows.
› Verified 7 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
Scientists are on their way to develop a perfect diet pill. The drug, which switches off appetite using hormones that are created naturally in the stomach when it is full, could be the first to be effective in weight loss without side effects.
Neurocrine Biosciences, Inc. has announced that they have resubmitted its New Drug Application (NDA) for indiplon 5 mg and 10 mg capsules for the treatment of insomnia in both adult and elderly patients to the U.S. Food and Drug Administration (FDA).
Researchers at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health and at the Harvard Medical School report that children with autism and gastrointestinal disturbances have altered expression of genes involved in digestion. These variations may contribute to changes in the types of bacteria in their intestines.
Stopping treatment with risperidone to limit side effects risks the return of psychosis or agitation in patients with Alzheimer's disease who have been taking the drug to suppress such symptoms, research shows.
› Verified 7 days ago
The patient survey data of Excellent Care Home Health Services, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 96 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 97 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 93 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 92 | 78 |
News Archive
Scientists are on their way to develop a perfect diet pill. The drug, which switches off appetite using hormones that are created naturally in the stomach when it is full, could be the first to be effective in weight loss without side effects.
Neurocrine Biosciences, Inc. has announced that they have resubmitted its New Drug Application (NDA) for indiplon 5 mg and 10 mg capsules for the treatment of insomnia in both adult and elderly patients to the U.S. Food and Drug Administration (FDA).
Researchers at the Center for Infection and Immunity (CII) at Columbia University's Mailman School of Public Health and at the Harvard Medical School report that children with autism and gastrointestinal disturbances have altered expression of genes involved in digestion. These variations may contribute to changes in the types of bacteria in their intestines.
Stopping treatment with risperidone to limit side effects risks the return of psychosis or agitation in patients with Alzheimer's disease who have been taking the drug to suppress such symptoms, research shows.
› Verified 7 days ago
Vineyard Home Healthcare Llc Location: 9605 Arrow Route, Suite S, Rancho Cucamonga, California 91730 Ratings: NA Phone: (909) 987-0300 | |
Alaphia Care Home Health Services, Inc. Location: 10630 Town Center Drive, Suite 116, Rancho Cucamonga, California 91730 Ratings: NA Phone: (909) 458-0578 | |
Visiting Home Nurses, Inc Location: 8273 White Oak Avenue Suite 110, Rancho Cucamonga, California 91730 Ratings: Phone: (909) 484-7881 | |
Vanura Home Health Services, Inc Location: 8213 Rochester Avenue, Rancho Cucamonga, California 91730 Ratings: Phone: (909) 989-1230 | |
Excellent Care Home Health Services, Inc Location: 9037 Arrow Route, Suite 140, Rancho Cucamonga, California 91730 Ratings: Phone: (909) 581-3536 | |
Inland Home Health Providers Inc Location: 9221 Archibald Avenue, Rancho Cucamonga, California 91730 Ratings: Phone: (909) 948-8731 |